|
ASPDH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.39729999792948E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.9382999982831E-08 |
| Normal-vs-Stage2 |
1.2650000047465E-08 |
| Normal-vs-Stage3 |
1.01470000180015E-08 |
| Normal-vs-Stage4 |
7.97830002063904E-09 |
| Stage1-vs-Stage2 |
5.576000E-01 |
| Stage1-vs-Stage3 |
2.278600E-01 |
| Stage1-vs-Stage4 |
9.988200E-02 |
| Stage2-vs-Stage3 |
8.030600E-01 |
| Stage2-vs-Stage4 |
5.649600E-01 |
| Stage3-vs-Stage4 |
7.331000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79019999935193E-08 |
| Normal-vs-AfricanAmerican |
8.92200002766685E-09 |
| Normal-vs-Asian |
4.39339997715393E-09 |
| Caucasian-vs-AfricanAmerican |
1.681950E-02 |
| Caucasian-vs-Asian |
6.93849999677809E-08 |
| AfricanAmerican-vs-Asian |
3.062000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59349999862002E-08 |
| Normal-vs-Female |
1.12419999975799E-08 |
| Male-vs-Female |
1.937030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.74240000205828E-08 |
| Normal-vs-Extreme_Weight |
1.38629999701934E-08 |
| Normal-vs-Obese |
1.60299999940605E-08 |
| Normal-vs-Extreme_Obese |
1.59830000345806E-08 |
| Normal_Weight-vs-Extreme_Weight |
5.711000E-01 |
| Normal_Weight-vs-Obese |
7.074400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.367200E-01 |
| Extreme_Weight-vs-Obese |
8.065800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.653800E-01 |
| Obese-vs-Extreme_Obese |
8.676200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.27169999980725E-08 |
| Normal-vs-Age(41-60Yrs) |
1.13479999841459E-08 |
| Normal-vs-Age(61-80Yrs) |
1.48169999603098E-08 |
| Normal-vs-Age(81-100Yrs) |
1.12619999992347E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.990600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.558600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.369200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.498200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.034800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.596220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.26479999806861E-08 |
| Normal-VS-Type2 PRCC |
3.73240000017816E-08 |
| Normal-VS-KIRP CIMP |
3.59749996459158E-09 |
| Normal-VS-Unclassified PRCC |
6.61319998762622E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.606050E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.05339997519872E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
2.146500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.04399999978355E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.591100E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.160500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.71939999804982E-08 |
| Normal-vs-N1 |
1.35209999863051E-08 |
| Normal-vs-N2 |
7.00629998462432E-09 |
| N0-vs-N1 |
4.222100E-02 |
| N0-vs-N2 |
3.340200E-03 |
| N1-vs-N2 |
8.928400E-02 |
|
|
